Skip to content
  • HOME
  • ABOUT

    MADE IN AMERICA.

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • ADVOCACY
    • STAFF
    • BOARD
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT CPA
    • ABOUT CPA
    • ADVOCACY
    • STAFF
    • BOARD
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT CPA
    LEARN MORE ➔
  • RESEARCH

    RESEARCH HUB

    The CPA Economics Team is focused on research into policies that can restore broadly shared U.S. prosperity, reduce our huge trade deficit, raise U.S. economic growth rate and reduce inequality.

    VISIT THE RESEARCH HUB

    ECONOMIC ISSUES

    • Trade & Tariffs
    • International Currencies
    • Economic Modeling
    • Industrial Strategy & Industry Studies
    • Labor & Inequality
    • Trade & Tariffs
    • International Currencies
    • Economic Modeling
    • Industrial Strategy & Industry Studies
    • Labor & Inequality

    MORE FROM CPA ECONOMICS

    • JOB QUALITY INDEX
    • CPA Trade Database
    • Domestic Market Share Index
    • Working Papers & Policy Papers
    • JOB QUALITY INDEX
    • CPA Trade Database
    • Domestic Market Share Index
    • Working Papers & Policy Papers
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

    CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

    May 23, 2025

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

    China Solar, Once Biggest Beneficiary of Inflation Reduction Act, No Longer Qualifies

    Distrust Grows: Reuters Report Suggests Chinese Solar Power Inverters Found with “Rogue Communication Device”

    In Senate Small Business Hearing, Democrats Bemoan Tariff “Chaos” as Republicans Increasingly Accept New Thinking on Trade

    MORE FROM THE NEWSROOM ➔
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

Supply Chain Crisis, Not Tariffs, Stoked Inflation

Archive, CPA News, Featured Home Page, Issues, Newsroom, Supply ChainBy Kenneth RapozaJune 21, 2023Leave a comment

Don’t blame the China tariffs on inflation. Supply chain snafus were a much bigger deal, a Federal Reserve report says.

Katherine Tai Says Globalization No Longer Sustainable

Archive, CPA News, Featured Home Page, Issues, Newsroom, Supply Chain, Trade and TariffsBy Kenneth RapozaJune 20, 2023Leave a comment

At National Press Club, Katherine Tai talks about supply chain issues, what ‘de-risking’ from China might look like, and how USTR thinks about it.

FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US

Archive, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Issues, Manufacturing, Newsroom, Supply ChainBy Kenneth RapozaJune 9, 2023Leave a comment

A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?

House Hearing on Dollar Focused on Sanctions Powers, ‘De-Dollarization’ Risks

Archive, CPA News, Currency, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 8, 2023Leave a comment

The House Financial Services Committee says American consumers are helped by a strong dollar, which lowers the price of imports to the tune of up to $45 billion per year in savings. In a $23 trillion economy, is an overvalued dollar really worth it?

U.S. Trade Deficit Rises 23% in April; Goods Gap Breaks Record For Year

Archive, CPA News, Featured Home Page, Issues, Newsroom, Trade and TariffsBy Kenneth RapozaJune 7, 2023Leave a comment

China as a source for American imports is on the wane thanks to tariffs, other business risks. But strong dollar keeps imports booming.

To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs

Archive, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.

Five China Companies Wall Street Still Funds Despite Being Blacklisted

Archive, Capital Markets, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

Meet the Chinese companies banned by Commerce and the State Department, but still able to attract billions from Wall Street fund managers.

FBI Faces Harsh Criticism in Homeland Security Committee China Hearing

Archive, China, CPA News, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

House Homeland Committee leadership say DoJ, FBI, and Homeland have all failed in stopping China espionage, IP theft.

Spotlight Shines on CPA in Latest House Ways & Means Trade Hearing

Archive, CPA News, Customs, Featured Home Page, Issues, NewsroomBy Kenneth RapozaMay 25, 2023Leave a comment

At a recent House Ways & Means subcommittee hearing on trade, CEO Michael Stumo talks de minimis, and the inescapable realities of China’s forced labor.

Congressman Dan Kildee’s Last Ditch Effort To Repeal Biden Solar Veto

Archive, CPA News, Featured Home Page, Issues, Manufacturing, Newsroom, Renewable EnergyBy Kenneth RapozaMay 24, 2023Leave a comment

Dan Kildee’s full floor speech in support of over-riding the President’s veto on House and Senate vote to end the White House solar emergency declaration started last June.

←1
23456789101112131415161718192021
…2223242526…
2728293031323334353637383940414243444546474849505152535455565758
59→
  • ABOUT
  • NEWSROOM
  • MEMBERSHIP
  • CONTACT
Facebook-f Youtube Linkedin

© 2025 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • RESEARCH
    • RESEARCH HUB
    • CPA ECONOMIC VIEW
    • TRADE & TARIFFS
    • CURRENCIES
    • MODELING
    • INDUSTRIAL STRATEGIES
    • LABOR & INEQUALITY
    • ECONOMICS CHARTS
    • ECONOMICS PRESENTATIONS
    • CURRENCY MISALIGNMENT MONITOR
    • DOMESTIC MARKET SHARE INDEX
    • TRADE DATABASE
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Twitter
 Facebook
 LinkedIn
 Copy
 Email

Share on Mastodon